Sumit Sharma - 24 Jul 2025 Form 4 Insider Report for MICROVISION, INC. (MVIS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
28 Jul 2025, 14:07:04 UTC
Prior SEC filing
06 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Drew G. Markham, as attorney-in-fact

Key filing fact

Sumit Sharma filed Form 4 for MICROVISION, INC. (MVIS) on 28 Jul 2025.

Key facts

  • This page summarizes Sumit Sharma's Form 4 filing for MICROVISION, INC. (MVIS).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 28 Jul 2025, 14:07.

Change

  • Previous filing in this sequence was filed on 06 Jun 2025.
  • Current net transaction value: -$450,733.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001709206 Primary reporting owner

Sharma Sumit

Relationship
CEO, Director
Address
18390 NE 68TH STREET, REDMOND
Signature
/s/ Drew G. Markham, as attorney-in-fact
Signature date
28 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MVIS transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+375,000
Change %
+42%
Price
$0.000000
Shares after
1,273,421
Date
24 Jul 2025
Ownership
Direct
Footnotes
F1
MVIS transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+371,250
Change %
+29%
Price
$0.000000
Shares after
1,644,671
Date
24 Jul 2025
Ownership
Direct
Footnotes
F1
MVIS transaction

Common Stock

Tax liability

Transaction value
$450,733
Shares
-341,931
Change %
-21%
Price
$1.32
Shares after
1,302,740
Date
25 Jul 2025
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MVIS transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+375,000
Change %
Price
$0.000000
Shares after
375,000
Date
24 Jul 2025
Ownership
Direct
Underlying class
Common stock
Underlying amount
375,000
Exercise price
$0.000000
Footnotes
F4, F5
MVIS transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-375,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
24 Jul 2025
Ownership
Direct
Underlying class
Common stock
Underlying amount
375,000
Exercise price
$0.000000
Footnotes
F5, F6
MVIS transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-371,250
Change %
-100%
Price
$0.000000
Shares after
0
Date
24 Jul 2025
Ownership
Direct
Underlying class
Common stock
Underlying amount
371,250
Exercise price
$0.000000
Footnotes
F6, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.

Footnote F2

Represents a withholding tax-related nondiscretionary sell-to-cover transaction completed by the Issuer in accordance with the terms of the award agreement.

Footnote F3

The price reported in column 4 is a weighted average price. These shares were sold by the Issuer in multiple transactions at prices ranging from $1.2801 to $1.37, inclusive.

Footnote F4

Each RSU represents a contingent right to receive one share of MicroVision common stock.

Footnote F5

RSUs vested on July 24, 2025, on the one-year anniversary of grant, upon determination by the Issuer's Compensation Committee of the level of achievement of performance objectives pursuant to the 2024 Executive Bonus Plan.

Footnote F6

At vesting, converts into shares of common stock on a unit-for-share basis.

Footnote F7

On July 27, 2024, the Issuer's Compensation Committee approved a grant of RSUs, which are scheduled to vest as to 33% on each annual anniversary of the grant date until fully vested on July 27, 2027, subject to the Reporting Person's continued employment with the Issuer on each vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .